Correlation Between Immuneering Corp and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Immuneering Corp and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immuneering Corp and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immuneering Corp and Enliven Therapeutics, you can compare the effects of market volatilities on Immuneering Corp and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immuneering Corp with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immuneering Corp and Enliven Therapeutics.
Diversification Opportunities for Immuneering Corp and Enliven Therapeutics
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Immuneering and Enliven is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Immuneering Corp and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Immuneering Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immuneering Corp are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Immuneering Corp i.e., Immuneering Corp and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Immuneering Corp and Enliven Therapeutics
Given the investment horizon of 90 days Immuneering Corp is expected to under-perform the Enliven Therapeutics. In addition to that, Immuneering Corp is 1.19 times more volatile than Enliven Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.09 per unit of volatility. If you would invest 2,390 in Enliven Therapeutics on November 3, 2024 and sell it today you would lose (204.00) from holding Enliven Therapeutics or give up 8.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Immuneering Corp vs. Enliven Therapeutics
Performance |
| Timeline |
| Immuneering Corp |
| Enliven Therapeutics |
Immuneering Corp and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immuneering Corp and Enliven Therapeutics
The main advantage of trading using opposite Immuneering Corp and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immuneering Corp position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Immuneering Corp vs. Pmv Pharmaceuticals | Immuneering Corp vs. Cullinan Oncology LLC | Immuneering Corp vs. Enliven Therapeutics | Immuneering Corp vs. Larimar Therapeutics |
| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |